To calculate the efficacy and safety of ABT-493/ABT-530 for HCV genotype 2 in Japan,Randomised non-blinded multicenter trial.
Not Applicable
- Conditions
- HCV genotype 2
- Registration Number
- JPRN-UMIN000022569
- Lead Sponsor
- Shinshu University of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1
Inclusion Criteria
Not provided
Exclusion Criteria
HCC
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SVR with 12 weeks after treatment
- Secondary Outcome Measures
Name Time Method